Navigation Links
Data Published in Nature Methods Demonstrate Breakthrough Ability to Accurately Detect Somatic Single Nucleotide Variations in Single Cells
Date:3/20/2017

NEW YORK, March 20, 2017 /PRNewswire/ -- SingulOmics Corporation, a recently established genomic research and service company, announced today the publication of data validating the company's core mission of producing a new, high quality amplification method and computational pipeline for single cell sequencing. The data demonstrate that the company's new system -- AccuSomatic Amplification for Single Cell Sequencing -- enables accurate detection of somatic single nucleotide variations (SNVs) in single cells not possible with any prior methods. The data are presented in a paper, "Accurate identification of single nucleotide variants in whole genome amplified single cells," published online on March 20, 2017 in Nature Methods (doi:10.1038/nmeth.4227).

AccuSomatic Amplification for Single Cell Sequencing, the result of years of research conducted at the Albert Einstein College of Medicine, New York, enables the discovery of true somatic SNVs in single cells that could not be accurately detected by any prior method. While single cell sequencing holds great promise for studying genetic heterogeneity in cancer and normal tissues, existing methods suffer from multiple sources of artifacts that can result in more than 20,000 false somatic SNV calls per cell and >90% false positive results. According to the research data, AccuSomatic Amplification eliminates >99% of errors in somatic SNV calls while maintaining the same detection sensitivity.  

"This is really a game changer for our research. We are interested in studying low, physiological levels of somatic SNVs and other mutations in single cells, but these were simply drowning in the high background we experienced with published protocols or commercially available systems," stated Jan Vijg, Ph.D., Chair, Department of Genetics, Albert Einstein College of Medicine and an investor and co-founder of SingulOmics. "We are entering a single cell genomics era as the cost of human genome sequencing plummets. This new method allows researchers to unlock the full potential of single cell sequencing in cancer, drug development, and aging research and greatly expands the capability of researchers to explore the landscapes of somatic mutations in human and other organisms beyond the reach of other amplification techniques available to date."

About SingulOmics
SingulOmics Corporation was established in 2016 in New York as a genomics research and service company specializing in the emerging field of single-cell omics. Building on the unmatched expertise in single-cell genomics, transcriptomics and epigenomics developed since the mid-2000s at the Albert Einstein College of Medicine, the company's mission is to develop and provide high-quality innovative single-cell services to academic and industrial communities around the world. In addition to AccuSomatic Amplification for Single Cell Sequencing, Singulomics also offers single cell whole genome bisulfite sequencing service. For more information, visit http://www.singulomics.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/data-published-in-nature-methods-demonstrate-breakthrough-ability-to-accurately-detect-somatic-single-nucleotide-variations-in-single-cells-300425847.html


'/>"/>
SOURCE SingulOmics Corporation
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Center Point Clinical Services Article Published in The Journal of Clinical Therapeutics
2. New Study Published in Lancet Respiratory Medicine Highlights QIAGENs QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants
3. Well-Controlled Clinical Study Published by Journal of Clinical Orthodontics Demonstrates Effect of Vibration on Molar Distalization Using AcceleDent
4. UV Disinfection Proven Effective by Newly-published Duke Health Study
5. Landmark Study Published Today in The Lancet Shows Clear Myeloma Survival Benefit with Triple Drug Combination
6. Medical Marijuana Temporary Regulations for Dispensaries to be Published in Tomorrows Pennsylvania Bulletin
7. NCCN Imaging Appropriate Use Criteria Published for 15 Additional Guidelines
8. LifeVac, Life Saving Device Study Published in American Journal of Emergency Medicine
9. Studies Show Ixekizumab Improved Work Productivity for Patients with Moderate-to-Severe Plaque Psoriasis: Results Published in JAMA Dermatology
10. Review of Delcath Melphalan/HDS System Published in "Cardiovascular & Interventional Radiology"
11. Results of the First Study to Establish a Link Between Twitter and Illegal Online Pharmacies Published in JMIR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it will release its ... host a conference call at 9:00am ET. The Company ... results and its strategy and outlook for the remainder ... Erez Raphael , Chief Executive Officer, and Zvi ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
(Date:8/7/2017)... 2017  Endo International plc (NASDAQ: ENDP ... virtually all known U.S. mesh product liability claims and ... known remaining U.S. claims at reasonable values. Under the ... fourth quarter of 2017 and continuing through the fourth ... 2017 results, the Company intends to increase its mesh ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... Immediate Release                Contact: Julian Teixeira, August 18, 2017                    202-478-8564 / jteixeira@thenc.org , ... from their Fathers , Contrary to a father’s perception, ...
(Date:8/18/2017)... New York, NY (PRWEB) , ... August 18, ... ... the launch of this summer’s edition of “Vision & Hearing,” advocating for active, ... The campaign focuses on resources available for individuals with hearing impairments and shares ...
(Date:8/18/2017)... O'Fallon, MO (PRWEB) , ... August 18, 2017 , ... ... Charles County, is inaugurating a new charity drive to generate community support for efforts ... for research into cures and treatments for all types of cancer. , Each ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning services to communities in east Texas, is launching a regional charity effort ... , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
Breaking Medicine News(10 mins):